Abstract: Embodiments of the present disclosure relate to antigen-binding affinity reagents for an analyte-of-interest. In particular, the present disclosure provides novel binding proteins (antibodies), including derivatives and fragments thereof, that target human CD30.
Type:
Grant
Filed:
September 27, 2023
Date of Patent:
October 22, 2024
Assignee:
R&D Systems, Inc.
Inventors:
Cyrus B. Munshi, Kerri Ann Bostrom, Julie Anne Werner, Lori Ann Heitkamp
Abstract: A control blood platelet preparation containing a population of platelets of known count range, electronic volume and electronic volume size distribution is used to check the threshold setting calibrations of an electronic particle counter. The control preparation preferably contains blood platelets from whole blood taken from animal species which are non-infectious with respect to human hepatitis, ideally animals of the bovine and parcine species.
Abstract: A control blood platelet preparation containing a population of platelets of known count range, electronic volume and electronic volume size distribution is ued to check the threshold setting calibrations of an electronic particle counter. The control preparation preferably contains blood platelets from whole blood taken from animal species which are non-injectious with respect to human hepatitis, ideally animals of the bovine and porcine species.